Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-06-27
2006-06-27
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S174000, C562S452000, C562S433000, C562S405000
Reexamination Certificate
active
07067530
ABSTRACT:
Novel compounds of general formula (I), the use of these compounds as medicaments, pharmaceuticaly compositions comprising the compounds and methods of treatment employing these compounds and compostiones. The present compounds may be useful in the treatment and/or prevention of conditions mediated by nuclear receptors, in particular the Peroxisome Proliferator-Activated Receptors (PPAR). The compounds exert their effects by modulating the PPARγ response in a partial agonist manner.
REFERENCES:
patent: 5306726 (1994-04-01), Hulin
patent: 0098690 (1984-01-01), None
patent: 1167357 (2002-01-01), None
patent: WO 91/19702 (1991-12-01), None
patent: WO 94/01420 (1994-01-01), None
patent: WO 99/19313 (1994-04-01), None
patent: WO 94/13650 (1994-06-01), None
patent: WO 94/29285 (1994-12-01), None
patent: WO 95/03038 (1995-02-01), None
patent: WO 95/17394 (1995-06-01), None
patent: WO 96/04260 (1996-02-01), None
patent: WO 97/25042 (1997-07-01), None
patent: WO 97/31907 (1997-09-01), None
patent: WO 97/36579 (1997-10-01), None
patent: WO 99/08501 (1999-02-01), None
patent: WO 99/16758 (1999-04-01), None
patent: WO 00/63153 (2000-10-01), None
patent: WO 01/00603 (2001-01-01), None
patent: WO 01/55085 (2001-08-01), None
Collins, J Med Chem, vol. 41, pp. 5037-5054, 1998.
Sorbera et al., Drugs of the Future 2001, vol. 26, No. 4, pp. 354-363.
Brown et al., Diabetes, vol. 48, pp. 1415-1424 (1999).
Henke et al., J. Med. Chem, vol. 41, pp. 5020-5036 (1998).
Collins et al., Journal of Medicinal Chemistry, vol. 41, No. 25, pp. 5037-5054 (1998).
Cobb et al., J. Med. Chem., vol. 41, pp. 5055-5069 (1998).
Abstract of Patent No. WO 97/43241.
Berger et al., The Journal of Biological Chemistry, vol. 274, No. 10, pp. 6718-6725 (1999).
Leibowitz, FEBS Letters, vol. 473, pp. 333-336 (2000).
Oliver et al., PNAS. vol. 98, No. 9, pp. 5306-5311 (2001).
Davis et al., Tetrahedron, vol. 55, pp. 11653-11667 (1999).
Bury Paul Stanley
Jeppesen Lone
Mogensen John Patrick
Pettersson Ingrid
Sauerberg Per
Bork Richard W.
Green Reza
Novo Nordisk A S
Seaman D. Margaret
Wilk-Orescan Rosemarie R.
LandOfFree
Compounds, their preparation and use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds, their preparation and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds, their preparation and use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3693349